Predicting Ki‐67 labeling index level in early‐stage lung adenocarcinomas manifesting as ground‐glass opacity nodules using intra‐nodular and peri‐nodular radiomic features
Open Access
- 24 March 2022
- journal article
- research article
- Published by Wiley in Cancer Medicine
- Vol. 11 (21) , 3982-3992
Abstract
Objectives: To explore the diagnostic value of radiomics in differentiating between lung adenocarcinomas appearing as ground‐glass opacity nodules (GGO) with high‐ and low Ki‐67 expression levels.Materials and Methods: From January 2018 to January 2021, patients with pulmonary GGO who received lung resection were evaluated for potential enrollment. The included GGOs were then randomly divided into a training cohort and a validation cohort with a ratio of 7:3. Logistic regression (LR), decision tree (DT), support vector machines (SVM), and adaboost (AB) were applied for radiomic model construction. Area under the curve (AUC) of the receiver operating characteristic (ROC) curve was used to evaluate the diagnostic efficacy of the established models.Results: Seven hundred and sixty‐nine patients with 769 GGOs were included in this study. Two hundred and forty‐five GGOs were confirmed to be of high Ki‐67 labeling index (LI). In the training cohort, gender, age, spiculation sign, pleural indentation sign, bubble sign, and maximum 2D diameter of the nodule were found to be significantly different between high‐ and low Ki‐67 LI groups (p < 0.05), and spiculation sign and maximum 2D diameter of the nodule were further confirmed to be risk factors for Ki‐67 LI. The radiomic model established using SVM exhibited an AUC of 0.731 in the validation cohort, which was higher than that of the clinical‐radiographic model (AUC = 0.675). Moreover, radiomic model combining both intra‐ and peri‐nodular features showed better diagnostic efficacy than using intra‐nodular features alone (AUC = 0.731 and 0.720, respectively).Conclusions: The established radiomic model exhibited good diagnostic efficacy in differentiating between lung adenocarcinoma GGOs with high and low Ki‐67 LI, which was higher than the clinical‐radiographic model. Peri‐nodular radiomic features showed added benefits to the radiomic model. As a novel noninvasive method, radiomics have the potential to be applied in the preliminary classification of Ki‐67 expression level in lung adenocarcinoma GGOs.Keywords
This publication has 31 references indexed in Scilit:
- Ki67 is a promising molecular target in the diagnosis of cancer (Review)Molecular Medicine Reports, 2014
- International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in womenLung Cancer, 2014
- Prognostic significance of Ki67 proliferation index, HIF1 alpha index and microvascular density in patients with non-small cell lung cancer brain metastasesStrahlentherapie und Onkologie, 2014
- PTEN and Ki67 expression is associated with clinicopathologic features of non-small cell lung cancerJournal of Biomedical Research, 2014
- Radiomics: the process and the challengesMagnetic Resonance Imaging, 2012
- Clinical Significance of Smac and Ki-67 Expression in Pancreatic CancerHepatogastroenterology, 2012
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomasLung Cancer, 2009
- Ki‐67 protein is associated with ribosomal RNA transcription in quiescent and proliferating cellsJournal of Cellular Physiology, 2005
- Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferationInternational Journal of Cancer, 1983